{"id":"comparator-diclofenac-sodium","safety":{"commonSideEffects":[{"rate":"10-20","effect":"Gastrointestinal upset (dyspepsia, nausea)"},{"rate":"5-15","effect":"Abdominal pain"},{"rate":"5-10","effect":"Headache"},{"rate":"3-9","effect":"Dizziness"},{"rate":"2-5","effect":"Rash"},{"rate":"1-3","effect":"Increased liver enzymes"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Diclofenac is a nonsteroidal anti-inflammatory drug (NSAID) that non-selectively blocks COX-1 and COX-2 enzymes. By inhibiting prostaglandin production, it reduces inflammatory mediators and provides analgesic and antipyretic effects. It is commonly used for short-term pain relief and inflammation management in various acute and chronic conditions.","oneSentence":"Diclofenac sodium inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis, thereby decreasing inflammation, pain, and fever.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:06:59.098Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute pain and inflammation"},{"name":"Rheumatoid arthritis"},{"name":"Osteoarthritis"},{"name":"Ankylosing spondylitis"},{"name":"Postoperative pain"}]},"trialDetails":[{"nctId":"NCT07475663","phase":"PHASE3","title":"Counterpain PXM Versus Diclofenac Versus Piroxicam","status":"COMPLETED","sponsor":"Taisho Pharmaceutical Indonesia","startDate":"2025-11-04","conditions":"Ankle Sprain, Back Pain, Osteoarthritis (OA) of the Knee","enrollment":180},{"nctId":"NCT06685445","phase":"NA","title":"Continue ESPB & Continue ESPB Combined With SAPB for Thoracotomy","status":"COMPLETED","sponsor":"Bursa City Hospital","startDate":"2024-10-18","conditions":"Post-thoracotomy Pain","enrollment":60},{"nctId":"NCT06632184","phase":"PHASE4","title":"Peritoneal Lavage Using Saline or Saline With Ondansetron for Pain Control After Laparoscopic Cholecystectomy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Instituto Mexicano del Seguro Social","startDate":"2025-12-01","conditions":"Postoperative Pain Management, Laparoscopic Cholecystectomy, Ondansetron","enrollment":40},{"nctId":"NCT06012097","phase":"PHASE4","title":"Impact of Gel Aromatherapy on Pain for Patients With De Quervain Disease","status":"RECRUITING","sponsor":"University Hospital, Strasbourg, France","startDate":"2024-06-04","conditions":"De Quervain Disease","enrollment":70},{"nctId":"NCT06905561","phase":"NA","title":"Topical Diclofenac for Prevention of Radiation-induced Dermatitis","status":"RECRUITING","sponsor":"The Second Affiliated Hospital of Hainan Medical University","startDate":"2025-02-13","conditions":"Head and Neck Tumor, Breast Cancer","enrollment":156},{"nctId":"NCT00140972","phase":"PHASE4","title":"A Study to Assess Etoricoxib Versus Diclofenac in Chinese Patients With Osteoarthritis of the Knee or Hip (0663-080)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2004-12-03","conditions":"Osteoarthritis","enrollment":160},{"nctId":"NCT00092703","phase":"PHASE3","title":"Investigational Drug Versus an Approved Drug in Patients With Osteoarthritis (0663-061)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2002-06-27","conditions":"Osteoarthritis","enrollment":6000},{"nctId":"NCT00542087","phase":"PHASE3","title":"Etoricoxib vs. Diclofenac in OA (0663-805)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2002-03-22","conditions":"Osteoarthritis","enrollment":516},{"nctId":"NCT04976088","phase":"PHASE3","title":"Clinical Trial With Diclofenac Sodium Medicated Plaster in Patients With Impact Injuries of the Limbs","status":"COMPLETED","sponsor":"Fidia Farmaceutici s.p.a.","startDate":"2018-05-25","conditions":"Trauma Injury, Inflammation","enrollment":214},{"nctId":"NCT05653401","phase":"PHASE2","title":"Treatment of Renal Colic in the Emergency Department: Comparison Between Magnesium Sulfate and Lidocaine.","status":"COMPLETED","sponsor":"University of Monastir","startDate":"2022-11-20","conditions":"Renal Colic","enrollment":800},{"nctId":"NCT03304379","phase":"PHASE3","title":"Study to Determine the Safety and the Efficacy of Fasinumab Compared to Placebo and Nonsteroidal Anti-inflammatory Drugs (NSAIDs) for Treatment of Adults With Pain From Osteoarthritis of the Knee or Hip","status":"COMPLETED","sponsor":"Regeneron Pharmaceuticals","startDate":"2017-10-26","conditions":"Osteoarthritis, Knee, Osteoarthritis, Hip","enrollment":1650},{"nctId":"NCT00242489","phase":"PHASE2","title":"Etoricoxib in the Treatment of Osteoarthritis (MK-0663-007)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"1998-06","conditions":"Osteoarthritis","enrollment":1167},{"nctId":"NCT00250445","phase":"PHASE3","title":"A Study to Evaluate the Safety of an Investigational Drug (Etoricoxib) in Patients With Osteoarthritis (OA) or Rheumatoid Arthritis (RA)(0663-066)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-01","conditions":"Rheumatoid Arthritis,Osteoarthritis","enrollment":23498},{"nctId":"NCT00092742","phase":"PHASE3","title":"Investigational Drug Versus an Approved Drug in Patients With Rheumatoid Arthritis (0663-072)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-02","conditions":"Rheumatoid Arthritis","enrollment":4086},{"nctId":"NCT00090181","phase":"PHASE4","title":"Study of MK0663 in Patients With Chronic Low Back Pain (0663-806)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2004-06","conditions":"Chronic Low Back Pain","enrollment":401},{"nctId":"NCT00264147","phase":"PHASE2","title":"Rheumatoid Arthritis Dose Ranging Study (0663-086)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-01","conditions":"Rheumatoid Arthritis","enrollment":761},{"nctId":"NCT03434197","phase":"PHASE3","title":"Safety and Efficacy of SFPP in Knee Osteoarthritis","status":"COMPLETED","sponsor":"Taisho Pharmaceutical Co., Ltd.","startDate":"2018-02-05","conditions":"Osteoarthritis Knee Pain","enrollment":313},{"nctId":"NCT03691844","phase":"PHASE2, PHASE3","title":"AMZ001 for the Treatment of Knee Osteoarthritis Symptoms","status":"COMPLETED","sponsor":"Amzell","startDate":"2018-10-04","conditions":"Osteoarthritis, Knee","enrollment":444},{"nctId":"NCT02985671","phase":"PHASE3","title":"To Evaluate the Superiority of Fixed Combination (Orfenadrine 35mg, Acetaminophen 325mg, Caffeine 65mg and Diclofenac Sodium 50mg) Compared to Voltaren® (Diclofenac Sodium 50mg) in the Treatment of Acute Postural Low Back Pain.","status":"UNKNOWN","sponsor":"Ache Laboratorios Farmaceuticos S.A.","startDate":"2021-01","conditions":"Postural Low Back Pain, Mechanical Low Back Pain","enrollment":110},{"nctId":"NCT03714672","phase":"PHASE3","title":"Tramadol/Diclofenac Fixed-dose Combination Phase III Trial in Acute Pain After Third Molar Extraction","status":"COMPLETED","sponsor":"Grünenthal GmbH","startDate":"2017-08-26","conditions":"Acute Pain","enrollment":1151},{"nctId":"NCT00140920","phase":"PHASE4","title":"A Study of Rofecoxib in the Treatment of Post-Operative Pain After Total Knee Joint Replacement (0966-259)","status":"TERMINATED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2004-05-25","conditions":"Pain","enrollment":11},{"nctId":"NCT00092378","phase":"PHASE3","title":"A Study of Two Approved Drugs in the Treatment of Post-Bunionectomy Surgery Pain (0966-234)(COMPLETED)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2003-09-01","conditions":"Postoperative Pain","enrollment":251},{"nctId":"NCT00931866","phase":"PHASE3","title":"Diclofenac Patch for Treatment of Acute Pain Due to Mild to Moderate Soft Tissue Injuries (TAPED)","status":"COMPLETED","sponsor":"Cerimon Pharmaceuticals","startDate":"2009-04","conditions":"Acute Pain, Soft Tissue Injury","enrollment":407},{"nctId":"NCT00869180","phase":"PHASE3","title":"Diclofenac Patch for Treatment of Acute Pain Due to Mild to Moderate Ankle Sprain","status":"COMPLETED","sponsor":"Cerimon Pharmaceuticals","startDate":"2009-02","conditions":"Acute Pain, Ankle Sprain","enrollment":219},{"nctId":"NCT00640705","phase":"PHASE2, PHASE3","title":"Diclofenac Patch for Treatment of Mild to Moderate Ankle Sprain","status":"TERMINATED","sponsor":"Cerimon Pharmaceuticals","startDate":"2008-01","conditions":"Ankle Sprain","enrollment":170},{"nctId":"NCT00640939","phase":"PHASE2, PHASE3","title":"Diclofenac Patch for Treatment of Mild to Moderate Tendonitis or Bursitis","status":"COMPLETED","sponsor":"Cerimon Pharmaceuticals","startDate":"2007-12","conditions":"Rotator Cuff Tendonitis, Bicipital Tendonitis, Subdeltoid Bursitis of the Shoulder","enrollment":308},{"nctId":"NCT00140933","phase":"PHASE3","title":"A Study to Evaluate Rofecoxib Versus Placebo and Diclofenac in Patients With Acute Painful Rotator Cuff Syndrome","status":"TERMINATED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2003-04","conditions":"Pain","enrollment":274}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1480,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Comparator: Diclofenac sodium","genericName":"Comparator: Diclofenac sodium","companyName":"Organon and Co","companyId":"organon-and-co","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Diclofenac sodium inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis, thereby decreasing inflammation, pain, and fever. Used for Acute pain and inflammation, Rheumatoid arthritis, Osteoarthritis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}